(Q45435711)

14 December 2017

title

Lamivudine treatment in a patient with hepatitis B virus reactivation after allogenic peripheral bone marrow transplantation (English)

1 reference

14 December 2017

1 reference

1 reference

Takaaki Imamura

1

1 reference

14 December 2017

Osamu Yokosuka

2

1 reference

14 December 2017

Tetsuhiro Chiba

3

1 reference

14 December 2017

Tatso Kanda

4

1 reference

14 December 2017

Hiroshige Kojima

5

1 reference

14 December 2017

Kenichi Fukai

6

1 reference

14 December 2017

Fumio Imazeki

7

1 reference

14 December 2017

Miki Nishimura

8

1 reference

14 December 2017

Yasushi Saito

9

1 reference

14 December 2017

Hiromitsu Saisho

10

1 reference

14 December 2017

publication date

1 June 2005

1 reference

14 December 2017

1 reference

14 December 2017

volume

46

1 reference

14 December 2017

issue

6

1 reference

14 December 2017

page(s)

915-917

1 reference

Treatment of HBV reactivation after withdrawal of immunosuppression

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190500051091

Prevalence of hepatitis B virus marker positivity and evolution of hepatitis B virus profile, during chemotherapy, in patients with solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500051091

Hepatitis B virus genotype assignment using restriction fragment length polymorphism patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500051091

High hepatitis B virus (HBV) DNA viral load as the most important risk factor for HBV reactivation in patients positive for HBV surface antigen undergoing autologous hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500051091

Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500051091

Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500051091

Hepatitis B genotypes in patients with acute hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500051091

Distribution of hepatitis B viral genotypes and mutations in the core promoter and precore regions in acute forms of liver disease in patients from Chiba, Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500051091

Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500051091

Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500051091

Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500051091

10.1080/10428190500051091

21 January 2018

Identifiers

DOI

1 reference

14 December 2017

1 reference